Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dermatological adverse events with taxane chemotherapy.
Sibaud V, Lebœuf NR, Roche H, Belum VR, Gladieff L, Deslandres M, Montastruc M, Eche A, Vigarios E, Dalenc F, Lacouture ME. Sibaud V, et al. Among authors: dalenc f. Eur J Dermatol. 2016 Oct 1;26(5):427-443. doi: 10.1684/ejd.2016.2833. Eur J Dermatol. 2016. PMID: 27550571 Free PMC article. Review.
Dexamethasone as a probe for docetaxel clearance.
Puisset F, Chatelut E, Dalenc F, Busi F, Cresteil T, Azéma J, Poublanc M, Hennebelle I, Lafont T, Chevreau C, Roché H. Puisset F, et al. Among authors: dalenc f. Cancer Chemother Pharmacol. 2004 Sep;54(3):265-72. doi: 10.1007/s00280-004-0823-0. Epub 2004 May 5. Cancer Chemother Pharmacol. 2004. PMID: 15133628 Clinical Trial.
Dexamethasone as a probe for vinorelbine clearance.
Puisset F, Dalenc F, Chatelut E, Cresteil T, Lochon I, Tisnes P, Roché H. Puisset F, et al. Among authors: dalenc f. Br J Clin Pharmacol. 2005 Jul;60(1):45-53. doi: 10.1111/j.1365-2125.2005.02384.x. Br J Clin Pharmacol. 2005. PMID: 15963093 Free PMC article. Clinical Trial.
[Pharmacological bases of intraperitoneal chemotherapy].
Gladieff L, Chatelut E, Dalenc F, Ferron G. Gladieff L, et al. Among authors: dalenc f. Bull Cancer. 2009 Dec;96(12):1235-42. doi: 10.1684/bdc.2009.0982. Bull Cancer. 2009. PMID: 19923051 Review. French.
Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast cancer: a negative phase II and screening of potential therapeutic markers by proteomic analysis.
Dalenc F, Doisneau-Sixou SF, Allal BC, Marsili S, Lauwers-Cances V, Chaoui K, Schiltz O, Monsarrat B, Filleron T, Renée N, Malissein E, Meunier E, Favre G, Roché H. Dalenc F, et al. Clin Cancer Res. 2010 Feb 15;16(4):1264-71. doi: 10.1158/1078-0432.CCR-09-1192. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145184 Clinical Trial.
225 results